http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4001251-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D461-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D461-00 |
filingDate | 1975-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1977-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c60cb7d414de5b538f32ab7cf8dddd53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58cd4d6db30c398f709e386b25bd758 |
publicationDate | 1977-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4001251-A |
titleOfInvention | Apovincaldehyde |
abstract | Vincamine and/or its stereoisomers, a known drug, is made from vincaminol and/or its stereoisomers by successive conversion of the latter into apovincaldehyde, apovincamine, and 16-methoxycarbonyl-eburnane, followed by conversion of the last into vincamine either directly by introduction of a 16-hydroxyl group or by hydrolysis, introduction of a 16-hydroxyl group, and re-esterification. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4883876-A |
priorityDate | 1972-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.